Ujwala Kaza is a board certified allergist that has been treating adults and children in New York City for over 10 years. She is a Clinical Assistant Professor at NYU’s School of Medicine where she teaches residents and medical students. She is also on staff at NYU Langone. Dr. Kaza is a Diplomate of the American Board of Allergy and Immunology. In addition, she is a fellow of both the American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology (AAAAI). She is a member of the New York Allergy and Asthma Society as well as the Joint Council of Allergy and Immunology.
Allergy for the Dermatologist, Parts 1 & 2
- When is further evaluation of urticarial necessary?
- When is allergy testing important and what kind of testing is necessary?
- What treatment exist for urticarial and when do I know to use them?
- New methods of diagnosis or treatment
- Availability of new medication(s) or indication(s)
- Advances in medical knowledge
- Journal of Allergy and Clinical Immunology. Kaplan, et al. “Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticarial”. Feb 2016;137(2):474-481.
- Middle’s Principles of Allergy and Immunology Textbook. 8th ed, Vol 1, Ch 36, pages 575-587.
Core Competencies: 2, 6
Disclosures: Pfizer, Astra Zeneca, Regeneron Sanofi Genzyme